RecruitingNot ApplicableNCT06683105

Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet

A Pilot Randomized Trial Investigating the MyIBDDiet App to Improve Self-management of an Anti-inflammatory Diet for Individuals With Inflammatory Bowel Disease


Sponsor

University of Alberta

Enrollment

40 participants

Start Date

Mar 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating. The main question\[s\] it aims to answer are: * Is the app easy to use? * Is the app useful? Researchers will compare the diet app to see if it is better at teaching patients about a healthy diet than the standard information they may receive from their doctor. Participants will be asked to use the app for one month and answer surveys to see how easy the app is to use and if it leads to healthier eating.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • ≥18 years
  • Able to provide informed consent
  • Established diagnosis of IBD determined by treating physician
  • Not in acute flare
  • Not pregnant
  • Willing and able to comply with all required study procedures

Exclusion Criteria10

  • Short bowel syndrome
  • High ostomy output
  • Intestinal strictures
  • Pregnancy or breastfeeding
  • Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) )
  • Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis)
  • Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis.
  • Currently on a therapeutic diet
  • Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet)
  • Active malignancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMyIBDDiet app

Participants in the Control crossover arm will be administered the intervention (using the app) for 30 days, and participants in the MYIBDDiet arm will use the app for 60 days.


Locations(1)

Zeidler Ledcor Centre, University of Alberta

Edmonton, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06683105


Related Trials